logo

For the Inventor, By the Inventor

Princeton Junction, NJ, United States of America

Wen-Chih Liu

This inventor holds 10 USPTO granted patents, plus 1 CIPO patent. Top assignee: E. R. Squibb Sons, Inc.. Active years: 1980-1994.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wen-Chih Liu. Retrieved from https://idiyas.com/inventor/wen-chih-liu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.3

ph-index = 3

Forward Citations = 52(Granted Patents)


Company Filing History:

goldMedal10 out of 1,624 
 
E. R. Squibb Sons, Inc.
 patents

Years Active: 1980-1994

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents
1. 5320955 - 10'desmethoxystreptonigrin production by Streptomyces albus (1994-06-14),
2. 5165931 - Peptifluorin and neopeptifluorin (1992-11-24),
3. 5158960 - 10'-Desmethoxystreptonigrin (1992-10-27),
4. 4745202 - Aerocyanidin-antibiotic (1988-05-17),
5. 4686299 - Aerocavin antibiotics (1987-08-11),
6. 4601904 - Antibiotics xylocandin A and xylocandin B (1986-07-22),
7. 4568675 - Phenazine ACE inhibitor produced from streptomyces species (1986-02-04),
8. 4339535 - Process for preparing antibiotic EM 4940 (1982-07-13),
9. 4249008 - 3,4-Dihydro-4-hydroxy-5-(3-hydroxy-2-pyridinyl)-4-me (1981-02-03),
10. 4213966 - Method for isolating polyether antibiotics (1980-07-22),

Title: The Innovative Contributions of Wen-Chih Liu

Introduction

Wen-Chih Liu is a prominent inventor based in Princeton Junction, NJ (US). He has made significant contributions to the field of antibiotic and antitumor compounds. With a total of 10 patents to his name, Liu's work has had a substantial impact on medical research and pharmaceutical development.

Latest Patents

Among his latest patents is the production of 10'-desmethoxystreptonigrin by Streptomyces albus. This compound, obtainable through the cultivation of a specific strain, exhibits notable antitumor and antibiotic activity. Additionally, Liu has developed two related novel antibiotic substances, peptifluorin and neopeptifluorin, which are prepared by cultivating strains of Pseudomonas fluorescens.

Career Highlights

Wen-Chih Liu is currently associated with E.R. Squibb & Sons, Inc., where he continues to innovate and contribute to the field of pharmaceuticals. His work has been instrumental in advancing the understanding and development of antibiotic agents.

Collaborations

Liu has collaborated with notable colleagues, including Richard B. Sykes and Edward Meyers, further enhancing the scope and impact of his research.

Conclusion

Wen-Chih Liu's innovative work in the field of antibiotics and antitumor compounds showcases his dedication to advancing medical science. His contributions continue to influence the pharmaceutical industry and improve health outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…